FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022679406> ?p ?o ?g. }

• W2022679406 endingPage "e4627" @default.
• W2022679406 startingPage "e4627" @default.
• W2022679406 abstract "To evaluate the cardiac safety of central nervous system stimulants in children and adolescents.Population based retrospective cohort study.Automated healthcare claims data from 1,219,847 children and young people eligible for 28 state Medicaid programmes from 1999 to 2006 linked to the Social Security Death Master File and the National Death Index.Children and young people age 3-18 entered the cohort at the first diagnosis of a mental health condition commonly treated with stimulants (such as attention-deficit/hyperactivity disorder) after a minimum period of six months' eligibility and were followed until loss of eligibility, their 19th birthday, admission to hospital for longer than 30 days, or death. Exclusion criteria included transplant recipients, receipt of dialysis, or claims indicating substance misuse. We retained high risk groups with similar use of stimulants as low risk children (such as children with congenital heart disease). Sociodemographic characteristics, cardiac risk factors, and psychiatric diagnoses obtained from before the index period were summarised with a propensity score. We used discrete survival analysis to estimate the relative risk for periods of stimulant use and non-use, adjusted for propensity score and antipsychotic use for the full cohort and the high risk and low risk groups.Composite endpoint of stroke, acute myocardial infarction, or sudden cardiac death; a secondary composite endpoint added ventricular arrhythmiaA total of 66 (95 including ventricular arrhythmia) events occurred during 2,321,311 years of follow-up. The odds ratio adjusted for propensity score and antipsychotic use for current versus no stimulant use was 0.62 (95% confidence interval 0.27 to 1.44), with a corresponding adjusted incidence rate of 2.2 and 3.5 per 100,000 patient years for current stimulant and non-use, respectively. Twenty six events occurred in high risk patients (incidence rate 63 per 100,000 patient years) with an odds ratio of 1.02 (0.28 to 3.69). Odds ratios for the secondary endpoint were similar to those for the primary endpoint (0.74, 0.38 to 1.46).Treatment of children with central nervous stimulants is not significantly associated with an increase in the short term risk of severe cardiac events. Analyses cannot be generalised to children with long term use of stimulants. Furthermore, long term effects of slight increases in heart rate or blood pressure are unknown." @default.
• W2022679406 created "2016-06-24" @default.
• W2022679406 creator A5003188866 @default.
• W2022679406 creator A5015272156 @default.
• W2022679406 creator A5019428397 @default.
• W2022679406 creator A5026681054 @default.
• W2022679406 creator A5039534762 @default.
• W2022679406 creator A5049902637 @default.
• W2022679406 creator A5062381819 @default.
• W2022679406 creator A5064006627 @default.
• W2022679406 creator A5065323624 @default.
• W2022679406 date "2012-07-18" @default.
• W2022679406 modified "2023-10-14" @default.
• W2022679406 title "Cardiovascular safety of central nervous system stimulants in children and adolescents: population based cohort study" @default.
• W2022679406 cites W1570154937 @default.
• W2022679406 cites W1580788756 @default.
• W2022679406 cites W182853122 @default.
• W2022679406 cites W1972053742 @default.
• W2022679406 cites W1973839018 @default.
• W2022679406 cites W1984198737 @default.
• W2022679406 cites W2017153406 @default.
• W2022679406 cites W2027058607 @default.
• W2022679406 cites W2032285255 @default.
• W2022679406 cites W2058328280 @default.
• W2022679406 cites W2070346839 @default.
• W2022679406 cites W2071193284 @default.
• W2022679406 cites W2091989291 @default.
• W2022679406 cites W2092123334 @default.
• W2022679406 cites W2106133175 @default.
• W2022679406 cites W2107612326 @default.
• W2022679406 cites W2111812421 @default.
• W2022679406 cites W2118215319 @default.
• W2022679406 cites W2122369545 @default.
• W2022679406 cites W2123132098 @default.
• W2022679406 cites W2136389780 @default.
• W2022679406 cites W2146506439 @default.
• W2022679406 cites W2150291618 @default.
• W2022679406 cites W2155350946 @default.
• W2022679406 cites W2164595809 @default.
• W2022679406 cites W2164676183 @default.
• W2022679406 cites W2167858830 @default.
• W2022679406 cites W2171956687 @default.
• W2022679406 cites W2601920136 @default.
• W2022679406 cites W2796700885 @default.
• W2022679406 cites W3175417087 @default.
• W2022679406 cites W67356013 @default.
• W2022679406 doi "https://doi.org/10.1136/bmj.e4627" @default.
• W2022679406 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3399772" @default.
• W2022679406 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22809800" @default.
• W2022679406 hasPublicationYear "2012" @default.
• W2022679406 type Work @default.
• W2022679406 sameAs 2022679406 @default.
• W2022679406 citedByCount "58" @default.
• W2022679406 countsByYear W20226794062012 @default.
• W2022679406 countsByYear W20226794062013 @default.
• W2022679406 countsByYear W20226794062014 @default.
• W2022679406 countsByYear W20226794062015 @default.
• W2022679406 countsByYear W20226794062016 @default.
• W2022679406 countsByYear W20226794062017 @default.
• W2022679406 countsByYear W20226794062018 @default.
• W2022679406 countsByYear W20226794062019 @default.
• W2022679406 countsByYear W20226794062020 @default.
• W2022679406 countsByYear W20226794062021 @default.
• W2022679406 countsByYear W20226794062022 @default.
• W2022679406 countsByYear W20226794062023 @default.
• W2022679406 crossrefType "journal-article" @default.
• W2022679406 hasAuthorship W2022679406A5003188866 @default.
• W2022679406 hasAuthorship W2022679406A5015272156 @default.
• W2022679406 hasAuthorship W2022679406A5019428397 @default.
• W2022679406 hasAuthorship W2022679406A5026681054 @default.
• W2022679406 hasAuthorship W2022679406A5039534762 @default.
• W2022679406 hasAuthorship W2022679406A5049902637 @default.
• W2022679406 hasAuthorship W2022679406A5062381819 @default.
• W2022679406 hasAuthorship W2022679406A5064006627 @default.
• W2022679406 hasAuthorship W2022679406A5065323624 @default.
• W2022679406 hasBestOaLocation W20226794061 @default.
• W2022679406 hasConcept C126322002 @default.
• W2022679406 hasConcept C127413603 @default.
• W2022679406 hasConcept C156957248 @default.
• W2022679406 hasConcept C167135981 @default.
• W2022679406 hasConcept C17923572 @default.
• W2022679406 hasConcept C187212893 @default.
• W2022679406 hasConcept C201903717 @default.
• W2022679406 hasConcept C2780645631 @default.
• W2022679406 hasConcept C2908647359 @default.
• W2022679406 hasConcept C71924100 @default.
• W2022679406 hasConcept C72563966 @default.
• W2022679406 hasConcept C78519656 @default.
• W2022679406 hasConcept C99454951 @default.
• W2022679406 hasConceptScore W2022679406C126322002 @default.
• W2022679406 hasConceptScore W2022679406C127413603 @default.
• W2022679406 hasConceptScore W2022679406C156957248 @default.
• W2022679406 hasConceptScore W2022679406C167135981 @default.
• W2022679406 hasConceptScore W2022679406C17923572 @default.
• W2022679406 hasConceptScore W2022679406C187212893 @default.
• W2022679406 hasConceptScore W2022679406C201903717 @default.
• W2022679406 hasConceptScore W2022679406C2780645631 @default.
• W2022679406 hasConceptScore W2022679406C2908647359 @default.

• next